NEXUS regularly publishes an update on further growth prospects

We presented our outlook until 2026 at this year's Berenberg German Corporate Conference in Munich, which was held from 19 to 21 September. After the strong growth of the last few years, the question of the further development of our company and our market has arisen.


We remain very optimistic for the period until 2026. Thanks to the positive market environment in the digitalization of healthcare and the numerous government support programs, we expect average organic growth of 8-9% p.a. until 2026.


Essential for this assessment is our strong product positioning and the focus on interoperability of our systems, which is resulting in numerous new orders.


In addition, we plan to realize further growth of approx. 4% p.a. on average through company acquisitions. The available liquid funds of approx. € 110 million are to be used for further European acquisitions in the healthcare market.


In total, we are aiming for sales of € 350-€ 360 million and an EBITDA of approx. € 90 million in 2026.


Donaueschingen, 22. September 2022


Management Team